BMP Pharma Trading FY26 first-half net profit rises 56.5% to EUR 3.13 million; revenue increases 13.18% to EUR 46.44 million

PUBT · 2d ago
BMP Pharma Trading FY26 first-half net profit rises 56.5% to EUR 3.13 million; revenue increases 13.18% to EUR 46.44 million
  • BMP Pharma Trading AG revenue rose 13.18% to EUR 46.4 million in the first half.
  • EBIT climbed to EUR 4.56 million, with management citing strong growth in active pharmaceutical ingredients.
  • Pretax profit increased to EUR 4.56 million; net profit advanced to EUR 3.13 million.
  • FX swung to a EUR 12,600 gain from a prior-period loss, supporting results.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BMP Pharma Trading AG published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.